• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SPL

STARPHARMA HOLDINGS LIMITED

0.00% ! 10.5¢
Market Cap $43.91M  !

Starpharma Holdings Limited is an Australia-based biotechnology company. The principal... Starpharma Holdings Limited is an Australia-based biotechnology company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its portfolio of dendrimer-based products includes three clinical-stage DEP (dendrimer enhanced product) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter (OTC) products. It has developed a pipeline of novel DEP oncology products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, it has a preclinical pipeline of DEP radiopharmaceuticals and DEP Antibody-Drug Conjugates (ADCs) in development. Its VIRALEZE Nasal Spray is a broad-spectrum nasal spray intended to provide a protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SPL
More radio program delays
10:51 6 1.1K
10:51 Last post  thrasher Comments Created with Sketch.  6  Views Created with Sketch.  1.1K 
SPL
2025 KPIs linked to a DEP deal, however…
07/08/25 17 4.2K
07/08/25 Last post  thrasher Comments Created with Sketch.  17  Views Created with Sketch.  4.2K 
SPL
My summary of the Quarterly Report
06/08/25 7 1.1K
06/08/25 Last post  thrasher Comments Created with Sketch.  7  Views Created with Sketch.  1.1K 
SPL
RED Flag: The evolving oncology landscape
06/08/25 10 1.8K
06/08/25 Last post  majestic001 Comments Created with Sketch.  10  Views Created with Sketch.  1.8K 
SPL
Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
06/08/25 1 300
06/08/25 Last post  thrasher Comments Created with Sketch.  1  Views Created with Sketch.  300 
SPL
MSD and Genentech
04/08/25 3 685
04/08/25 Last post  Starlink Comments Created with Sketch.  3  Views Created with Sketch.  685 
SPL
The DEP pipeline: Zero success
04/08/25 1 289
04/08/25 Last post  thrasher Comments Created with Sketch.  1  Views Created with Sketch.  289 
SPL
DEP-SN38 early phase trial results just published in American Society of Clinical Oncology
04/08/25 0 476
04/08/25 Last post  antibotter Comments Created with Sketch.  0  Views Created with Sketch.  476 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 09:49
 
Notification of cessation of securities - SPL
08 Jul 08:53
 
Change in substantial holding
04 Jun 08:19
 
Change in substantial holding
03 Jun 16:28
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:33
 
Notification of cessation of securities - SPL
04 Apr 10:05
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $43.91M
Open High Low Value Volume
10.5¢ 10.5¢ 10.5¢ $10.75K 102.4K

Buyers (Bids)

No. Vol. Price($)
2 145354 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 64314 3
View Market Depth
Last trade - 11.36am 08/08/2025 (20 minute delay) ?
Last
10.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
10.5¢ 10.5¢ 10.5¢ 47000
Last updated 11.36am 08/08/2025 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.